InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,658.00
(
0.32%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.17
(
0.26%
)
Bitcoin
62,824.72
(
-0.35%
)
Post# of 251777
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: jq1234 post# 209422

Saturday, 02/25/2017 8:21:02 PM

Saturday, February 25, 2017 8:21:02 PM

Post# of 251777
Velcade: IDMC stopped trial at 3rd planned interim.


"After the IDMC reviewed the data from the third interim analysis, the Sponsor was notified that the pre-specified statistical boundary for the primary endpoint of TTP was crossed, as of the clinical cut-off date, with 65% (253/390 events) of the required TTP events of PD or relapse (Vc-MP: 101 events, MP: 152 events) reported. "
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up